A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) – Study protocol for a randomised controlled trial

BACKGROUND: Human papillomavirus (HPV) infection is the primary cause of cervical cancer. In 2018, the World Health Organization (WHO) Director General announced his commitment to eliminate cervical cancer, with HPV vaccination as a priority. However, the costs of setting up a multi-dose HPV vaccina...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Contemp Clin Trials
Main Authors: Baisley, Kathy J., Whitworth, Hilary S., Changalucha, John, Pinto, Ligia, Dillner, Joakim, Kapiga, Saidi, de Sanjosé, Silvia, Mayaud, Philippe, Hayes, Richard J., Lacey, Charles J., Watson-Jones, Deborah
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7970022/
https://ncbi.nlm.nih.gov/pubmed/33421649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2021.106266
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares